THE AMERICAN pharmaceutical industry is under assault. Patients are upset about the high prices of medicines. Congressional committees and consumer groups are aroused by reports of high profits. And the president of the United States has repeatedly promised to "crack down" on pharmaceutical companies, presumably through some form of price control.